ArticleJournal of diabetes2026

SGLT2 Inhibitors Are Associated With Suppression of the Sema3A/NRP1/Plexin-A1 Signaling Axis in Postmenopausal Women With Type 2 Diabetes: Evidence From Propensity Score-Matched Analysis.

Sertas Erarslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.